Delivery Order SPE2DB22D2007-SPE2DB24FJ5DS

Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Sandostatin LAR Depot 30 mg kits. The contract has a total ceiling value of $63,249.07 and an ultimate completion date of September 5, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568189974 Sandostatin LAR Depot 10 mg kits. The contract has a firm fixed price of $2,030.13 and a completion date of May 9, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $6,631.54 and covers the procurement of Sandostatin LAR Depot 10 mg kits, a specialty medication. The contract has an ultimate completion date of December 27, 2024 and is a firm fixed-price type. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company, for the supply of Sandostatin LAR Depot 30 mg kits. The order, valued at $14,628.94, has an ultimate completion date of March 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sandostatin LAR Depot 20 mg kits, a specialty medication used to treat certain medical conditions. The contract has a ceiling value of $9,657.77 and an ultimate completion date of December 31, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is...
This is a delivery order under a broader Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $3,914.52 and is for the delivery of Sandostatin LAR Depot 30 mg kits, a specialty medication. The order has a firm fixed price and a completion date of February 20, 2024. This contract award is not designated as a set-aside and is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty pharmaceutical product. The contract has a ceiling value of $36,174.35 and a period of performance through September 16, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,849.62 firm fixed-price contract is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty medication used to treat certain medical conditions. The contract has an ultimate completion date of November 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This delivery order award, valued at $27,818.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Sandostatin LAR Depot 30 mg Kits. The contract has an ultimate completion date of September 13, 2024. AmerisourceBergen, as a major pharmaceutical distributor, holds multiple indefinite delivery contracts (IDCs) with DLA and other federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of medical commodities....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the supply of Sandostatin LAR Depot 30 mg kits, a specialty pharmaceutical product. The fixed-price contract has a ceiling value of $3,914.52 and a period of performance through March 13, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ5DS
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Sandostatin LAR Depot 30 mg kits. The contract has a ceiling value of $11,812.54 and an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities, including critical care materials and a diverse array of medications. The contract does not have a set-aside designation.

Generated 11/15/24, 9:24 AM